Blue-Ribbon Panel Begins Process Of Closing Up Shop

At an April 1 meeting in Washington, D.C., the Carnegie Commission on Science, Technology, and Government formally began the process of going out of business. The commission's five-year charter ends June 30. The panel was convened in 1988 under the auspices of the Carnegie Corporation of New York to assess the ways in which policymakers take science and technology issues into account when making decisions. The blue-ribbon panel is cochaired by Nobel laureate Joshua Lederberg, former president

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

The panel was convened in 1988 under the auspices of the Carnegie Corporation of New York to assess the ways in which policymakers take science and technology issues into account when making decisions. The blue-ribbon panel is cochaired by Nobel laureate Joshua Lederberg, former president of Rockefeller University, and William T. Golden, chairman of the board of the American Museum of Natural History in New York, who formerly served as a special consultant on scientific activities to President Harry Truman.

Included among the members of the commission and its advisory council are some of the United States' most prominent scientists, Republican Gerald Ford); three former U.S. senators (Republicans Charles McC. Mathias, Jr. of Maryland and Daniel Evans of Washington, as well as Democrat Lawton Chiles of Florida); three former U.S. representatives (Democrats John Brademas of Indiana and Paul Rogers of Florida, as well as Mathias, who served in the House ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Barbara Spector

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide